Sunday, October 26, 2008

Transcept Pharmaceuticals Submits New Drug Application For Intermezzo(R) For Treatment Of Middle-of-the-Night Awakenings

Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate, Intermezzo(R) (zolpidem tartrate sublingual lozenge). More at...

Delayed sleep phase syndrome (DSPS) is often misdiagnosed as a sleep disorder. Learn more about the causes and symptoms of DSPS. More at...

A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that unrelated to obesity, people with severe SDBs consume a more unhealthy diet, which may be a factor contributing to greater cardiovascular morbidity and mortality. These findings were most evident among women. More at...

Title: Suicide Warning Signs
Category: Doctor's Views
Created: 10/21/2008
Last Editorial Review: 10/21/2008 More at...

Sexsomnia, also known as sexsleep or sleep sex, is a parasomnia that causes a person to have sex while sleeping. Learn more about sexsomnia. More at...

The breathing and heart rates and cortisol levels of women with metastatic breast cancer can be used to predict if they'll suffer from chronic insomnia and sleep disruptions, a common complaint from patients who want to maintain their quality of life, according to a study by scientists at the University of Rochester Medical Center. More at...

Title: Brain Pressure More Likely to Cause Vision Loss in Men
Category: Health News
Created: 10/16/2008 2:00:00 AM
Last Editorial Review: 10/16/2008 More at...

0 comments: